Trademark: 79277182
Word
TWOB-IG
Status
Registered
Status Code
700
Status Date
Tuesday, January 11, 2022
Serial Number
79277182
Registration Number
6610075
Registration Date
Tuesday, January 11, 2022
Mark Type
4000
Filing Date
Wednesday, September 25, 2019
Published for Opposition
Tuesday, October 26, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations for human use for preventing or treating infectious and parasitic diseases, cancer, blood and blood-forming organs diseases and disorders involving the immune mechanism, endocrine, nutritional and metabolic diseases, mental and behavioral disorders, diseases of the nervous system, diseases of the eye and adnexa, diseases of the ear and mastoid process, diseases of the circulatory system, diseases of the respiratory system, diseases of the digestive system, diseases of the skin and subcutaneous tissue, diseases of the musculoskeletal system and connective tissue, diseases of the genitourinary system, complications in pregnancy, childbirth and the puerperium, certain conditions originating in the perinatal period, congenital malformations, deformations and chromosomal abnormalities, namely, pharmaceutical antibodies or its fragments or its derivatives, cells and genes that produce antibodies, fragments of antibodies or derivatives of antibodies for medical and pharmaceutical use
45 Granting of licenses to others for the use of industrial property rights and copyright
42 Pharmaceutical research and development services and providing information about medical and scientific research in the field of pharmaceuticals
TWO BIG

Trademark Events
Aug 1, 2022
Final Decision Transaction Processed By Ib
Jun 24, 2022
Generic Madrid Transaction Sent To Ib
Jun 23, 2022
Generic Madrid Transaction Created
Apr 11, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jan 11, 2022
Registered-Principal Register
Nov 4, 2021
Notification Processed By Ib
Oct 26, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 26, 2021
Published For Opposition
Oct 6, 2021
Notification Of Possible Opposition Sent To Ib
Oct 6, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 6, 2021
Notification Of Notice Of Publication E-Mailed
Sep 16, 2021
Approved For Pub - Principal Register
Jul 18, 2021
Notification Of Possible Opposition - Processed By Ib
Jul 16, 2021
Teas/Email Correspondence Entered
Jul 16, 2021
Correspondence Received In Law Office
Jul 16, 2021
Teas Response To Office Action Received
Jun 30, 2021
Notification Of Possible Opposition Sent To Ib
Jun 30, 2021
Notification Of Possible Opposition Created, To Be Sent To Ib
Apr 7, 2021
Notification Of Non-Final Action E-Mailed
Apr 7, 2021
Non-Final Action E-Mailed
Apr 7, 2021
Non-Final Action Written
Apr 7, 2021
Previous Allowance Count Withdrawn
Apr 7, 2021
Approved For Pub - Principal Register
Mar 18, 2021
Teas/Email Correspondence Entered
Mar 17, 2021
Correspondence Received In Law Office
Mar 17, 2021
Teas Response To Office Action Received
Oct 6, 2020
Notification Of Non-Final Action E-Mailed
Oct 6, 2020
Non-Final Action E-Mailed
Oct 6, 2020
Non-Final Action Written
Sep 10, 2020
Teas/Email Correspondence Entered
Sep 9, 2020
Correspondence Received In Law Office
Sep 9, 2020
Teas Response To Office Action Received
Mar 31, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Mar 31, 2020
Teas Change Of Correspondence Received
Mar 31, 2020
Teas Change Of Domestic Representatives Address
Mar 31, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 31, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 31, 2020
Teas Change Of Owner Address Received
Mar 27, 2020
Refusal Processed By Ib
Mar 9, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Mar 9, 2020
Refusal Processed By Mpu
Feb 17, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Feb 16, 2020
Non-Final Action Written
Feb 7, 2020
Application Filing Receipt Mailed
Feb 3, 2020
Assigned To Examiner
Feb 3, 2020
New Application Office Supplied Data Entered In Tram
Jan 30, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24